Brought to you by 
Sandoz acquires Sabex for €460mm cash
Jun 2004
Executive Summary
Novartis AG's generics subsidiary Sandoz will pay €460mm ($565mm) in cash to acquire its Canadian competitor Sabex. The purchase price is about six times the acquired company's $90mm recorded sales of last year.
Deal Industry
-
Pharmaceuticals
- Generic Drugs
Deal Status
- Final
Deal Type
-
Acquisition
- Payment Includes Cash
- Full Acquisition
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Sandoz acquires Sabex for €460mm cash
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice